Relajación residual en la unidad de cuidado posanestésico

Autores:: Reyes, Luis Eduardo
Valencia, Ana Ruth
Campo, Carlos Andrés
Muñoz, Luis Alfonso

Tipo de recurso:: Article of journal

Fecha de publicación:: 2015

Institución:: Fundación Universitaria de Ciencias de la Salud - FUCS

Repositorio:: Repositorio Digital Institucional ReDi

Idioma:: spa

id	FUCS2_cc9c598c0ccc63adf7583b42b06e36f6
oai_identifier_str	oai:repositorio.fucsalud.edu.co:001/2488
network_acronym_str	FUCS2
network_name_str	Repositorio Digital Institucional ReDi
repository_id_str
dc.title.spa.fl_str_mv	Relajación residual en la unidad de cuidado posanestésico
dc.title.translated.eng.fl_str_mv	Residual relaxation in the posanesthetic care unit
title	Relajación residual en la unidad de cuidado posanestésico
spellingShingle	Relajación residual en la unidad de cuidado posanestésico monitoreo del bloqueo neuromuscular bloqueo neuromuscular posoperatorio drogas bloqueadoras neuromusculares de acción intermedia unidad de cuidados posanestésicos (UCPA) parálisis residual posoperatoria (PORC) monitoring of neuromuscular block postoperative neuromuscular block intermediate-acting neuromuscular blocking drugs post-anesthetic care unit (PACU) postoperative residual paralysis (PORC)
title_short	Relajación residual en la unidad de cuidado posanestésico
title_full	Relajación residual en la unidad de cuidado posanestésico
title_fullStr	Relajación residual en la unidad de cuidado posanestésico
title_full_unstemmed	Relajación residual en la unidad de cuidado posanestésico
title_sort	Relajación residual en la unidad de cuidado posanestésico
dc.creator.fl_str_mv	Reyes, Luis Eduardo Valencia, Ana Ruth Campo, Carlos Andrés Muñoz, Luis Alfonso
dc.contributor.author.spa.fl_str_mv	Reyes, Luis Eduardo Valencia, Ana Ruth Campo, Carlos Andrés Muñoz, Luis Alfonso
dc.subject.spa.fl_str_mv	monitoreo del bloqueo neuromuscular bloqueo neuromuscular posoperatorio drogas bloqueadoras neuromusculares de acción intermedia unidad de cuidados posanestésicos (UCPA) parálisis residual posoperatoria (PORC)
topic	monitoreo del bloqueo neuromuscular bloqueo neuromuscular posoperatorio drogas bloqueadoras neuromusculares de acción intermedia unidad de cuidados posanestésicos (UCPA) parálisis residual posoperatoria (PORC) monitoring of neuromuscular block postoperative neuromuscular block intermediate-acting neuromuscular blocking drugs post-anesthetic care unit (PACU) postoperative residual paralysis (PORC)
dc.subject.eng.fl_str_mv	monitoring of neuromuscular block postoperative neuromuscular block intermediate-acting neuromuscular blocking drugs post-anesthetic care unit (PACU) postoperative residual paralysis (PORC)
publishDate	2015
dc.date.accessioned.none.fl_str_mv	2015-12-01 00:00:00 2022-02-21T20:37:59Z
dc.date.issued.none.fl_str_mv	2015-12-01
dc.date.available.none.fl_str_mv	2015-12-01 00:00:00 2022-02-21T20:37:59Z
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.eng.fl_str_mv	Journal article
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv	Text
dc.type.coarversion.spa.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.doi.none.fl_str_mv	10.31260/RepertMedCir.v24.n4.2015.598
dc.identifier.issn.none.fl_str_mv	0121-7372
dc.identifier.uri.none.fl_str_mv	https://repositorio.fucsalud.edu.co/handle/001/2488
dc.identifier.eissn.none.fl_str_mv	2462-991X
dc.identifier.url.none.fl_str_mv	https://doi.org/10.31260/RepertMedCir.v24.n4.2015.598
identifier_str_mv	10.31260/RepertMedCir.v24.n4.2015.598 0121-7372 2462-991X
url	https://repositorio.fucsalud.edu.co/handle/001/2488 https://doi.org/10.31260/RepertMedCir.v24.n4.2015.598
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.references.spa.fl_str_mv	Brull SJ, Murphy GS. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesth Analg. 2010;111(1): 129-40. Combes X, Andriamifidy L, Dufresne E, Suen P, Sauvat S, Scherrer E, et al. Comparison of two induction regimens using or not using muscle relaxant: impact on postoperative upper airway discomfort. Br J Anaesth. 2007;99(2):276-81. Andersen BN, Madsen JV, Schurizek BA, Juhl B. Residual curarisation: a comparative study of atracurium and pancuronium. Acta Anaesthesiol Scand. 1988;32(2):79-81. Claudius C, Garvey LH, Viby-Mogensen J. The undesirable effects of neuromuscular blocking drugs. Anaesthesia. 2009;64 Suppl 1:10-21. Craig RG, Hunter JM. Neuromuscular blocking drugs and their antagonists in patients with organ disease. Anaesthesia. 2009;64 Suppl 1:55-65. Murphy GS. Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period. Minerva Anestesiol. 2006;72(3):97-109. Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg. 2010;111(1):110-9. Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology. 2010;112(4):1013-22. Capron F, Alla F, Hottier C, Meistelman C, Fuchs-Buder T. Can acceleromyography detect low levels of residual paralysis? A probability approach to detect a mechanomyographic train-of-four ratio of 0.9. Anesthesiology. 2004;100(5):1119-24. Ali HH, Wilson RS, Savarese JJ, Kitz RJ. The effect of tubocurarine on indirectly elicited train-of-four muscle response and respiratory measurements in humans. Br J Anaesth. 1975;47(5):570-4. Murphy GS, Szokol JW, Marymont JH, Franklin M, Avram MJ, Vender JS. Residual paralysis at the time of tracheal extubation. Anesth Analg. 2005;100(6):1840-5. Cammu G, De Witte J, De Veylder J, Byttebier G, Vandeput D, Foubert L, et al. Postoperative residual paralysis in outpatients versus inpatients. Anesth Analg. 2006;102(2):426-9. Fuchs-Buder T, Hofmockel R, Geldner G, Diefenbach C, Ulm K, Blobner M. [The use of neuromuscular monitoring in Germany]. Anaesthesist. 2003;52(6):522-6. Maybauer DM, Geldner G, Blobner M, Pühringer F, Hofmockel R, Rex C, et al. Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium. Anaesthesia. 2007;62(1):12-7. Fawcett WJ, Dash A, Francis GA, Liban JB, Cashman JN. Recovery from neuromuscular blockade: residual curarisation following atracurium or vecuronium by bolus dosing or infusions. Acta Anaesthesiol Scand. 1995;39(3):288-93. Ronald MD. Miller Anestesia. Elsevier ed2011. Kopman AF, Yee PS, Neuman GG. Relationship of the train-of-fourfade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology. 1997;86(4):765-71. Grayling M, Sweeney BP. Recovery from neuromuscular blockade: a survey of practice. Anaesthesia. 2007;62(8):806-9. Fuchs-Buder T, Schreiber JU, Meistelman C. Monitoring neuromuscular block: an update. Anaesthesia. 2009;64 Suppl 1:82-9. Claudius C, Viby-Mogensen J. Acceleromyography for use in scientific and clinical practice: a systematic review of the evidence. Anesthesiology. 2008; 108(6):1117-40. 21 Naguib M, Lien CA, Meistelman C. Anesthesia. 6 ed. Philadelphia: Elsevier/ Churchill Livingstone; 2005. Chapter 34, Pharmacology of Neuromuscular Blocking Drugs; 958-994.e8. Cai YR, Xu J, Chen LH, Chi FL. Electromyographic monitoring of facial nerve under different levels of neuromuscular blockade during middle ear microsurgery. Chin Med J (Engl). 2009;122(3):311-4. Jellish WS, Leonetti JP, Buoy CM, Sincacore JM, Sawicki KJ, Macken MP. Facial nerve electromyographic monitoring to predict movement in patients titrated to a standard anesthetic depth. Anesth Analg. 2009;109(2):551-8. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008;107(1):130-7. Fuchs-Buder T, Meistelman C, Alla F, Grandjean A, Wuthrich Y, Donati F. Antagonism of low degrees of atracurium-induced neuromuscular blockade: doseeffect relationship for neostigmine. Anesthesiology. 2010;112(1):34-40. Caldwell JE. Clinical limitations of acetylcholinesterase antagonists. J Crit Care. 2009;24(1):21-8. Bom A, Hope F, Rutherford S, Thomson K. Preclinical pharmacology of sugammadex. J Crit Care. 2009;24(1):29-35. Jones RK, Caldwell JE, Brull SJ, Soto RG. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology. 2008;109(5):816-24. Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg. 2007;104(3):575-81. Claudius C, Karacan H, Viby-Mogensen J. Prolonged residual paralysis after a single intubating dose of rocuronium. Br J Anaesth. 2007;99(4):514-7. Arain SR, Kern S, Ficke DJ, Ebert TJ. Variability of duration of action of neuromuscular-blocking drugs in elderly patients. Acta Anaesthesiol Scand. 2005;49(3):312-5. Herbstreit F, Peters J, Eikermann M. Impaired upper airway integrity by residual neuromuscular blockade: increased airway collapsibility and blunted genioglossus muscle activity in response to negative pharyngeal pressure. Anesthesiology. 2009;110(6):1253-60. Lee C, Katz RL. Clinical implications of new neuromuscular concepts and agents: so long, neostigmine! So long, sux! J Crit Care. 2009;24(1):43-9. Eikermann M, Vogt FM, Herbstreit F, Vahid-Dastgerdi M, Zenge MO, Ochterbeck C, et al. The predisposition to inspiratory upper airway collapse during partial neuromuscular blockade. Am J Respir Crit Care Med. 2007;175(1):9-15.
dc.relation.bitstream.none.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/598/636
dc.relation.citationedition.spa.fl_str_mv	Núm. 4 , Año 2015 : Octubre – Diciembre
dc.relation.citationendpage.none.fl_str_mv	260
dc.relation.citationissue.spa.fl_str_mv	4
dc.relation.citationstartpage.none.fl_str_mv	254
dc.relation.citationvolume.spa.fl_str_mv	24
dc.relation.ispartofjournal.spa.fl_str_mv	Revista Repertorio de Medicina y Cirugía
dc.rights.spa.fl_str_mv	Fundación Universitaria de Ciencias de la Salud FUCS - 0
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
dc.rights.uri.spa.fl_str_mv	https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv	Fundación Universitaria de Ciencias de la Salud FUCS - 0 https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.source.spa.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/598
institution	Fundación Universitaria de Ciencias de la Salud - FUCS
bitstream.url.fl_str_mv	https://repositorio.fucsalud.edu.co/bitstreams/4bb93d08-f51e-4a4a-aae2-c5be71a585f2/download
bitstream.checksum.fl_str_mv	deea2e98c6234f836fc4b32591fc1b3a
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud
repository.mail.fl_str_mv	redi@fucsalud.edu.co
_version_	1808413874407342080
spelling	Reyes, Luis Eduardob027e6d2aed3232cb9b0839e54c5d0c6500Valencia, Ana Ruthed5c7f17308994fb3edf30464b531b6d300Campo, Carlos Andrésbb9289ee8aacf4fc485d5731a38adbc7300Muñoz, Luis Alfonsod27e41b9eed672806dc316890fa485e85002015-12-01 00:00:002022-02-21T20:37:59Z2015-12-012015-12-01 00:00:002022-02-21T20:37:59ZSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la SaludFundación Universitaria de Ciencias de la Salud FUCS - 0info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/598monitoreo del bloqueo neuromuscularbloqueo neuromuscular posoperatoriodrogas bloqueadoras neuromusculares de acción intermediaunidad de cuidados posanestésicos (UCPA)parálisis residual posoperatoria (PORC)monitoring of neuromuscular blockpostoperative neuromuscular blockintermediate-acting neuromuscular blocking drugspost-anesthetic care unit (PACU)postoperative residual paralysis (PORC)Relajación residual en la unidad de cuidado posanestésicoResidual relaxation in the posanesthetic care unitapplication/pdfArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/coar/version/c_970fb48d4fbd8a8510.31260/RepertMedCir.v24.n4.2015.5980121-7372https://repositorio.fucsalud.edu.co/handle/001/24882462-991Xhttps://doi.org/10.31260/RepertMedCir.v24.n4.2015.598spaBrull SJ, Murphy GS. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesth Analg. 2010;111(1): 129-40.Combes X, Andriamifidy L, Dufresne E, Suen P, Sauvat S, Scherrer E, et al. Comparison of two induction regimens using or not using muscle relaxant: impact on postoperative upper airway discomfort. Br J Anaesth. 2007;99(2):276-81.Andersen BN, Madsen JV, Schurizek BA, Juhl B. Residual curarisation: a comparative study of atracurium and pancuronium. Acta Anaesthesiol Scand. 1988;32(2):79-81.Claudius C, Garvey LH, Viby-Mogensen J. The undesirable effects of neuromuscular blocking drugs. Anaesthesia. 2009;64 Suppl 1:10-21.Craig RG, Hunter JM. Neuromuscular blocking drugs and their antagonists in patients with organ disease. Anaesthesia. 2009;64 Suppl 1:55-65.Murphy GS. Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period. Minerva Anestesiol. 2006;72(3):97-109.Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg. 2010;111(1):110-9.Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology. 2010;112(4):1013-22.Capron F, Alla F, Hottier C, Meistelman C, Fuchs-Buder T. Can acceleromyography detect low levels of residual paralysis? A probability approach to detect a mechanomyographic train-of-four ratio of 0.9. Anesthesiology. 2004;100(5):1119-24.Ali HH, Wilson RS, Savarese JJ, Kitz RJ. The effect of tubocurarine on indirectly elicited train-of-four muscle response and respiratory measurements in humans. Br J Anaesth. 1975;47(5):570-4.Murphy GS, Szokol JW, Marymont JH, Franklin M, Avram MJ, Vender JS. Residual paralysis at the time of tracheal extubation. Anesth Analg. 2005;100(6):1840-5.Cammu G, De Witte J, De Veylder J, Byttebier G, Vandeput D, Foubert L, et al. Postoperative residual paralysis in outpatients versus inpatients. Anesth Analg. 2006;102(2):426-9.Fuchs-Buder T, Hofmockel R, Geldner G, Diefenbach C, Ulm K, Blobner M. [The use of neuromuscular monitoring in Germany]. Anaesthesist. 2003;52(6):522-6.Maybauer DM, Geldner G, Blobner M, Pühringer F, Hofmockel R, Rex C, et al. Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium. Anaesthesia. 2007;62(1):12-7.Fawcett WJ, Dash A, Francis GA, Liban JB, Cashman JN. Recovery from neuromuscular blockade: residual curarisation following atracurium or vecuronium by bolus dosing or infusions. Acta Anaesthesiol Scand. 1995;39(3):288-93.Ronald MD. Miller Anestesia. Elsevier ed2011.Kopman AF, Yee PS, Neuman GG. Relationship of the train-of-fourfade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology. 1997;86(4):765-71.Grayling M, Sweeney BP. Recovery from neuromuscular blockade: a survey of practice. Anaesthesia. 2007;62(8):806-9.Fuchs-Buder T, Schreiber JU, Meistelman C. Monitoring neuromuscular block: an update. Anaesthesia. 2009;64 Suppl 1:82-9.Claudius C, Viby-Mogensen J. Acceleromyography for use in scientific and clinical practice: a systematic review of the evidence. Anesthesiology. 2008; 108(6):1117-40.21 Naguib M, Lien CA, Meistelman C. Anesthesia. 6 ed. Philadelphia: Elsevier/ Churchill Livingstone; 2005. Chapter 34, Pharmacology of Neuromuscular Blocking Drugs; 958-994.e8.Cai YR, Xu J, Chen LH, Chi FL. Electromyographic monitoring of facial nerve under different levels of neuromuscular blockade during middle ear microsurgery. Chin Med J (Engl). 2009;122(3):311-4.Jellish WS, Leonetti JP, Buoy CM, Sincacore JM, Sawicki KJ, Macken MP. Facial nerve electromyographic monitoring to predict movement in patients titrated to a standard anesthetic depth. Anesth Analg. 2009;109(2):551-8.Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008;107(1):130-7.Fuchs-Buder T, Meistelman C, Alla F, Grandjean A, Wuthrich Y, Donati F. Antagonism of low degrees of atracurium-induced neuromuscular blockade: doseeffect relationship for neostigmine. Anesthesiology. 2010;112(1):34-40.Caldwell JE. Clinical limitations of acetylcholinesterase antagonists. J Crit Care. 2009;24(1):21-8.Bom A, Hope F, Rutherford S, Thomson K. Preclinical pharmacology of sugammadex. J Crit Care. 2009;24(1):29-35.Jones RK, Caldwell JE, Brull SJ, Soto RG. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology. 2008;109(5):816-24.Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg. 2007;104(3):575-81.Claudius C, Karacan H, Viby-Mogensen J. Prolonged residual paralysis after a single intubating dose of rocuronium. Br J Anaesth. 2007;99(4):514-7.Arain SR, Kern S, Ficke DJ, Ebert TJ. Variability of duration of action of neuromuscular-blocking drugs in elderly patients. Acta Anaesthesiol Scand. 2005;49(3):312-5.Herbstreit F, Peters J, Eikermann M. Impaired upper airway integrity by residual neuromuscular blockade: increased airway collapsibility and blunted genioglossus muscle activity in response to negative pharyngeal pressure. Anesthesiology. 2009;110(6):1253-60.Lee C, Katz RL. Clinical implications of new neuromuscular concepts and agents: so long, neostigmine! So long, sux! J Crit Care. 2009;24(1):43-9.Eikermann M, Vogt FM, Herbstreit F, Vahid-Dastgerdi M, Zenge MO, Ochterbeck C, et al. The predisposition to inspiratory upper airway collapse during partial neuromuscular blockade. Am J Respir Crit Care Med. 2007;175(1):9-15.https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/598/636Núm. 4 , Año 2015 : Octubre – Diciembre260425424Revista Repertorio de Medicina y CirugíaPublicationOREORE.xmltext/xml2494https://repositorio.fucsalud.edu.co/bitstreams/4bb93d08-f51e-4a4a-aae2-c5be71a585f2/downloaddeea2e98c6234f836fc4b32591fc1b3aMD51001/2488oai:repositorio.fucsalud.edu.co:001/24882024-02-02 13:08:30.287https://creativecommons.org/licenses/by-nc-sa/4.0/Fundación Universitaria de Ciencias de la Salud FUCS - 0metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co

Relajación residual en la unidad de cuidado posanestésico

Publicaciones similares